{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:39:53Z","timestamp":1788910793704,"version":"build-2803163510"},"reference-count":161,"publisher":"Bentham Science Publishers Ltd.","issue":"28","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2019,12,19]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Candida species are the important etiologic agents for candidiasis, the most prevalent cause of opportunistic fungal infections. Candida invasion results in mucosal to systemic infections through immune dysfunction and helps in further invasion and proliferation at several sites in the host. The host defence system utilizes a wide array of the cells, proteins and chemical signals that are distributed in blood and tissues which further constitute the innate and adaptive immune system. The lack of antifungal agents and their limited therapeutic effects have led to high mortality and morbidity related to such infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The necessary information collated on this review has been gathered from various literature published from 1995 to 2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>This article sheds light on novel drug delivery approaches to target the immunological axis for several Candida species (C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. rugose, C. hemulonii, etc.).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>It is clear that the novel drug delivery approaches include vaccines, adoptive transfer of primed immune cells, recombinant cytokines, therapeutic antibodies, and nanoparticles, which have immunomodulatory effects. Such advancements in targeting various underpinning mechanisms using the concept of novel drug delivery will provide a new dimension to the fungal infection clinic particularly due to Candida species with improved patient compliance and lesser side effects. This advancement in knowledge can also be extended to target various other similar microbial species and infections.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1568026619666191026105308","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T07:42:03Z","timestamp":1573890123000},"page":"2593-2609","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species"],"prefix":"10.2174","volume":"19","author":[{"given":"Ridhima","family":"Wadhwa","sequence":"first","affiliation":[{"name":"Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parijat","family":"Pandey","sequence":"additional","affiliation":[{"name":"Shri Baba Mastnath Institute of Pharmaceutical Sciences and Research, Baba Mastnath University, Rohtak 124001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302 017, Jaipur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University, Noida 201303, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Amity Institute for Advanced Research & Studies (M&D), Amity University, Noida 201303, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenu","family":"Mehta","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara-144411, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Satija","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara-144411, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Delhi G.T. Road (NH-1), Phagwara-144411, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna R.","family":"Madan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune, 411048, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Dureja","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Maharishi Dayanand University, Rohtak, Haryana 124001, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri R.","family":"Balusamy","sequence":"additional","affiliation":[{"name":"Department of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul, 05006, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haribalan","family":"Perumalsamy","sequence":"additional","affiliation":[{"name":"Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin, 446-701, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Maurya","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Central University of Haryana, Jant-Pali, Mahendergarh District 123031, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trudi","family":"Collet","sequence":"additional","affiliation":[{"name":"Innovative Medicines Group, Institute of Health & Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, BT52 1SA, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[{"name":"School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh 173 229, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/jof4040129","volume":"4","author":"Arikan-Akdagli S.","year":"2018","unstructured":"Arikan-Akdagli S.; Ghannoum M.; Meis J.F.; Antifungal resistance: specific focus on multidrug resistance in candida auris and secondary azole resistance in aspergillus fumigatus. J Fungi (Basel) 2018,4(4),129","journal-title":"J Fungi (Basel)"},{"key":"ref=2","first-page":"388","volume":"25","author":"Ko J.H.","year":"2018","unstructured":"Ko J.H.; Jung D.S.; Lee J.Y.; Kim H.A.; Ryu S.Y.; Jung S.I.; Joo E.J.; Cheon S.; Kim Y.S.; Kim S.W.; Cho S.Y.; Kang C.I.; Chung D.R.; Lee N.Y.; Peck K.R.; Changing epidemiology of non-albicans candidemia in Korea. J Infect Chemother 2018,25(5),388","journal-title":"J Infect Chemother"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/myc.12898","volume":"62","author":"Nasri E.","year":"2019","unstructured":"Nasri E.; Fakhim H.; Vaezi A.; Khalilzadeh S.; Ahangarkani F.; Laal Kargar M.; Abtahian Z.; Badali H.; Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients. Mycoses 2019,62(5),434-440","journal-title":"Mycoses"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/myc.12900","volume":"62","author":"Ota\u0161evi\u0107 S.","year":"2019","unstructured":"Ota\u0161evi\u0107 S.; Mom\u010dilovi\u0107 S.; Golubovi\u0107 M.; Ignjatovi\u0107 A.; Ran\u010di\u0107 N.; \u0110or\u0111evi\u0107 M.; Ran\u0111elovi\u0107 M.; Hay R.; Arsi\u0107-Arsenijevi\u0107 V.; Species distribution and epidemiological characteristics of superficial fungal infections in Southeastern Serbia. Mycoses 2019,62(5),458-465","journal-title":"Mycoses"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jvim.15444","volume":"33","author":"Reagan K.L.","year":"2019","unstructured":"Reagan K.L.; Dear J.D.; Kass P.H.; Sykes J.E.; Risk factors for Candida urinary tract infections in dogs and cats. J Vet Intern Med 2019,33(2),648-653","journal-title":"J Vet Intern Med"},{"key":"ref=6","volume":"24","author":"Schlager E.","year":"2018","unstructured":"Schlager E.; Ashack K.; Khachemoune A.; Erosio interdigitalis blastomycetica: A review of interdigital candidiasis. Dermatol Online J 13030\/qt8tm443f6.2018,24(8)","journal-title":"Dermatol Online J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jof5010011","volume":"5","author":"Walsh T.J.","year":"2019","unstructured":"Walsh T.J.; Katragkou A.; Chen T.; Salvatore C.M.; Roilides E.; Invasive candidiasis in infants and children: Recent advances in epidemiology, diagnosis, and treatment. J Fungi (Basel) 2019,5(1),11","journal-title":"J Fungi (Basel)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3389\/fmicb.2018.02477","volume":"9","author":"Abe M.","year":"2018","unstructured":"Abe M.; Kinjo Y.; Ueno K.; Takatsuka S.; Nakamura S.; Ogura S.; Kimura M.; Araoka H.; Sadamoto S.; Shinozaki M.; Shibuya K.; Yoneyama A.; Kaku M.; Miyazaki Y.; Differences in ocular complications between candida albicans and non-albicans candida infection analyzed by epidemiology and a mouse ocular candidiasis model. Front Microbiol 2018,9,2477","journal-title":"Front Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s12879-018-3512-z","volume":"18","author":"Awad L.","year":"2018","unstructured":"Awad L.; Tamim H.; Abdallah D.; Salameh M.; Mugharbil A.; Jisr T.; Zahran K.; Droubi N.; Ibrahim A.; Moghnieh R.; Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre. BMC Infect Dis 2018,18(1),589","journal-title":"BMC Infect Dis"},{"key":"ref=10","first-page":"730","volume":"53","author":"Cao H.F.","year":"2018","unstructured":"Cao H.F.; Dong Y.; Yang T.; Li B.B.; Zhao J.; [Prevalence of candida albicans and its relationship with early childhood caries among children of three ethnic groups (Han, Uygur, Mongolian) in bortala mongol autonomous prefecture of xinjiang uygur autonomous region]. Zhonghua kou qiang yi xue za zhi 2018,53(11),730","journal-title":"Zhonghua kou qiang yi xue za zhi"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","volume":"6","author":"Cortegiani A.","year":"2018","unstructured":"Cortegiani A.; Misseri G.; Fasciana T.; Giammanco A.; Giarratano A.; Chowdhary A.; Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care 2018,6,69","journal-title":"J Intensive Care"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18502\/cmm.4.2.64","volume":"4","author":"Sadrossadati S.Z.","year":"2018","unstructured":"Sadrossadati S.Z.; Ghahri M.; Imani Fooladi A.A.; Sayyahfar S.; Beyraghi S.; Baseri Z.; Phenotypic and genotypic characterization of Candida species isolated from candideamia in Iran. Curr Med Mycol 2018,4(2),14-20","journal-title":"Curr Med Mycol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e00709","DOI":"10.1128\/mSphere.00709-18","volume":"4","author":"Marton T.","year":"2019","unstructured":"Marton T.; Feri A.; Commere P.H.; Maufrais C.; d\u2019Enfert C.; Legrand M.; Identification of recessive lethal alleles in the diploid genome of a candida albicans laboratory strain unveils a potential role of repetitive sequences in buffering their deleterious impact. MSphere 2019,4(1),e00709-e00718","journal-title":"MSphere"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmicb.2019.00027","volume":"10","author":"Shimamura S.","year":"2019","unstructured":"Shimamura S.; Miyazaki T.; Tashiro M.; Takazono T.; Saijo T.; Yamamoto K.; Imamura Y.; Izumikawa K.; Yanagihara K.; Kohno S.; Mukae H.; Autophagy-inducing factor atg1 is required for virulence in the pathogenic fungus candida glabrata. Front Microbiol 2019,10,27","journal-title":"Front Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fmicb.2019.00099","volume":"10","author":"Van Ende M.","year":"2019","unstructured":"Van Ende M.; Wijnants S.; Van Dijck P.; Sugar Sensing and Signaling in Candida albicans and Candida glabrata. Front Microbiol 2019,10,99","journal-title":"Front Microbiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1128\/JCM.00007-19","volume":"57","author":"Welsh R.M.","year":"2019","unstructured":"Welsh R.M.; Sexton D.J.; Forsberg K.; Vallabhaneni S.; Litvintseva A.; Insights into the unique nature of the east asian clade of the emerging pathogenic yeast candida auris. J Clin Microbiol 2019,57(4),e00007-e00019","journal-title":"J Clin Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e00002","DOI":"10.1128\/mSphere.00002-19","volume":"4","author":"Wensing L.","year":"2019","unstructured":"Wensing L.; Sharma J.; Uthayakumar D.; Proteau Y.; Chavez A.; Shapiro R.S.; A CRISPR Interference platform for efficient genetic repression in candida albicans. MSphere 2019,4(1),e00002-e00019","journal-title":"MSphere"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"Pfaller M.A.","year":"2007","unstructured":"Pfaller M.A.; Diekema D.J.; Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007,20(1),133-163","journal-title":"Clin Microbiol Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/378745","volume":"37","author":"Gudlaugsson O.","year":"2003","unstructured":"Gudlaugsson O.; Gillespie S.; Lee K.; Vande Berg J.; Hu J.; Messer S.; Herwaldt L.; Pfaller M.; Diekema D.; Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003,37(9),1172-1177","journal-title":"Clin Infect Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"Pappas P.G.","year":"2009","unstructured":"Pappas P.G.; Kauffman C.A.; Andes D.; Benjamin D.K.; Calandra T.F.; Edwards J.E.; Filler S.G.; Fisher J.F.; Kullberg B-J.; Ostrosky-Zeichner L.; Clinical practice guidelines for the management of candidiasis: 2009 update of the infectious diseases society of America. Clin Infect Dis 2009,48(5),503-537","journal-title":"Clin Infect Dis"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1086\/513640","volume":"24","author":"Pittet D.","year":"1997","unstructured":"Pittet D.; Li N.; Woolson R.F.; Wenzel R.P.; Microbiological factors influencing the outcome of nosocomial bloodstream infections: A 6-year validated, population-based model. Clin Infect Dis 1997,24(6),1068-1078","journal-title":"Clin Infect Dis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1086\/496922","volume":"41","author":"Zaoutis T.E.","year":"2005","unstructured":"Zaoutis T.E.; Argon J.; Chu J.; Berlin J.A.; Walsh T.J.; Feudtner C.; The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005,41(9),1232-1239","journal-title":"Clin Infect Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1046\/j.1524-4733.2002.51108.x","volume":"5","author":"Wilson L.S.","year":"2002","unstructured":"Wilson L.S.; Reyes C.M.; Stolpman M.; Speckman J.; Allen K.; Beney J.; The direct cost and incidence of systemic fungal infections. Value Health 2002,5(1),26-34","journal-title":"Value Health"},{"key":"ref=24","first-page":"20","volume":"2","author":"Bhattacharjee P.","year":"2016","unstructured":"Bhattacharjee P.; Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India. Curr Med Mycol 2016,2(2),20","journal-title":"Curr Med Mycol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"Guinea J.","year":"2014","unstructured":"Guinea J.; Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect 2014,20(Suppl. 6),5-10","journal-title":"Clin Microbiol Infect"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"Janeway C.A.","year":"2002","unstructured":"Janeway C.A.; Medzhitov R.; Innate immune recognition. Annu Rev Immunol 2002,20(1),197-216","journal-title":"Annu Rev Immunol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/08830185.2013.777065","volume":"32","author":"Plato A.","year":"2013","unstructured":"Plato A.; Willment J.A.; Brown G.D.; C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. Int Rev Immunol 2013,32(2),134-156","journal-title":"Int Rev Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fcimb.2012.00142","volume":"2","author":"Bourgeois C.","year":"2012","unstructured":"Bourgeois C.; Kuchler K.; Fungal pathogens-a sweet and sour treat for toll-like receptors. Front Cell Infect Microbiol 2012,2,142","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"Takeuchi O.","year":"2010","unstructured":"Takeuchi O.; Akira S.; Pattern recognition receptors and inflammation. Cell 2010,140(6),805-820","journal-title":"Cell"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/527696","volume":"2015","author":"Rogier R.","year":"2015","unstructured":"Rogier R.; Koenders M.I.; Abdollahi-Roodsaz S.; Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res 2015,2015","journal-title":"J Immunol Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1152\/advan.00058.2013","volume":"37","author":"Suresh R.","year":"2013","unstructured":"Suresh R.; Mosser D.M.; Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ 2013,37(4),284-291","journal-title":"Adv Physiol Educ"},{"key":"ref=32","author":"Pang B.","year":"2013","unstructured":"Pang B.; Efficient search and comparison algorithms for 3D protein binding site retrieval and structure alignment from large-scale databases. PhD Thesis, University of Missouri: Columbia, 2013","journal-title":"PhD Thesis, University of Missouri: Columbia,"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fimmu.2018.00804","volume":"9","author":"Del Fresno C.","year":"2018","unstructured":"Del Fresno C.; Iborra S.; Saz-Leal P.; Mart\u00ednez-L\u00f3pez M.; Sancho D.; Flexible signaling of myeloid C-type lectin receptors in immunity and inflammation. Front Immunol 2018,9,804","journal-title":"Front Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2011.11.015","volume":"36","author":"Strasser D.","year":"2012","unstructured":"Strasser D.; Neumann K.; Bergmann H.; Marakalala M.J.; Guler R.; Rojowska A.; Hopfner K-P.; Brombacher F.; Urlaub H.; Baier G.; Brown G.D.; Leitges M.; Ruland J.; Syk kinase-coupled C-type lectin receptors engage protein kinase C-\u03c3 to elicit Card9 adaptor-mediated innate immunity. Immunity 2012,36(1),32-42","journal-title":"Immunity"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ni.1692","volume":"10","author":"Gringhuis S.I.","year":"2009","unstructured":"Gringhuis S.I.; den Dunnen J.; Litjens M.; van der Vlist M.; Wevers B.; Bruijns S.C.; Geijtenbeek T.B.; Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 2009,10(2),203-213","journal-title":"Nat Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1182\/blood-2014-01-551473","volume":"124","author":"Gazendam R.P.","year":"2014","unstructured":"Gazendam R.P.; van Hamme J.L.; Tool A.T.; van Houdt M.; Verkuijlen P.J.; Herbst M.; Liese J.G.; van de Veerdonk F.L.; Roos D.; van den Berg T.K.; Kuijpers T.W.; Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood 2014,124(4),590-597","journal-title":"Blood"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molimm.2009.09.018","volume":"47","author":"van Bruggen R.","year":"2009","unstructured":"van Bruggen R.; Drewniak A.; Jansen M.; van Houdt M.; Roos D.; Chapel H.; Verhoeven A.J.; Kuijpers T.W.; Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for \u03b2-glucan-bearing particles. Mol Immunol 2009,47(2-3),575-581","journal-title":"Mol Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrmicro1815","volume":"6","author":"Netea M.G.","year":"2008","unstructured":"Netea M.G.; Brown G.D.; Kullberg B.J.; Gow N.A.; An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008,6(1),67-78","journal-title":"Nat Rev Microbiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"20590","DOI":"10.1074\/jbc.M709334200","volume":"283","author":"Cambi A.","year":"2008","unstructured":"Cambi A.; Netea M.G.; Mora-Montes H.M.; Gow N.A.; Hato S.V.; Lowman D.W.; Kullberg B-J.; Torensma R.; Williams D.L.; Figdor C.G.; Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J Biol Chem 2008,283(29),20590-20599","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20082109","volume":"206","author":"Means T.K.","year":"2009","unstructured":"Means T.K.; Mylonakis E.; Tampakakis E.; Colvin R.A.; Seung E.; Puckett L.; Tai M.F.; Stewart C.R.; Pukkila-Worley R.; Hickman S.E.; Moore K.J.; Calderwood S.B.; Hacohen N.; Luster A.D.; El Khoury J.; Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med 2009,206(3),637-653","journal-title":"J Exp Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/21505594.2015.1014270","volume":"6","author":"Zheng N-X.","year":"2015","unstructured":"Zheng N-X.; Wang Y.; Hu D-D.; Yan L.; Jiang Y-Y.; The role of pattern recognition receptors in the innate recognition of Candida albicans. Virulence 2015,6(4),347-361","journal-title":"Virulence"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00430-013-0288-z","volume":"202","author":"Miram\u00f3n P.","year":"2013","unstructured":"Miram\u00f3n P.; Kasper L.; Hube B.; Thriving within the host: Candida spp. interactions with phagocytic cells. Med Microbiol Immunol (Berl) 2013,202(3),183-195","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4049\/jimmunol.1200185","volume":"189","author":"Svobodov\u00e1 E.","year":"2012","unstructured":"Svobodov\u00e1 E.; Staib P.; Losse J.; Hennicke F.; Barz D.; J\u00f3zsi M.; Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils. J Immunol 2012,189(5),2502-2511","journal-title":"J Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","volume":"30","author":"Amulic B.","year":"2012","unstructured":"Amulic B.; Cazalet C.; Hayes G.L.; Metzler K.D.; Zychlinsky A.; Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012,30,459-489","journal-title":"Annu Rev Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4049\/jimmunol.1300113","volume":"191","author":"Mattila J.T.","year":"2013","unstructured":"Mattila J.T.; Ojo O.O.; Kepka-Lenhart D.; Marino S.; Kim J.H.; Eum S.Y.; Via L.E.; Barry C.E.; Klein E.; Kirschner D.E.; Morris S.M.; Lin P.L.; Flynn J.L.; Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J Immunol 2013,191(2),773-784","journal-title":"J Immunol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.4049\/jimmunol.167.11.6533","volume":"167","author":"Hesse M.","year":"2001","unstructured":"Hesse M.; Modolell M.; La Flamme A.C.; Schito M.; Fuentes J.M.; Cheever A.W.; Pearce E.J.; Wynn T.A.; Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1\/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 2001,167(11),6533-6544","journal-title":"J Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003741","volume":"9","author":"Jim\u00e9nez-L\u00f3pez C.","year":"2013","unstructured":"Jim\u00e9nez-L\u00f3pez C.; Lorenz M.C.; Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages. PLoS Pathog 2013,9(11)","journal-title":"PLoS Pathog"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/mi.2009.17","volume":"2","author":"Bonifazi P.","year":"2009","unstructured":"Bonifazi P.; Zelante T.; D\u2019Angelo C.; De Luca A.; Moretti S.; Bozza S.; Perruccio K.; Iannitti R.G.; Giovannini G.; Volpi C.; Fallarino F.; Puccetti P.; Romani L.; Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2009,2(4),362-374","journal-title":"Mucosal Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nri1255","volume":"4","author":"Romani L.","year":"2004","unstructured":"Romani L.; Immunity to fungal infections. Nat Rev Immunol 2004,4(1),1-23","journal-title":"Nat Rev Immunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/infdis\/171.5.1279","volume":"171","author":"Cenci E.","year":"1995","unstructured":"Cenci E.; Mencacci A.; Spaccapelo R.; Tonnetti L.; Mosci P.; Enssle K-H.; Puccetti P.; Romani L.; Bistoni F.; T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995,171(5),1279-1288","journal-title":"J Infect Dis"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001259","volume":"7","author":"Gringhuis S.I.","year":"2011","unstructured":"Gringhuis S.I.; Wevers B.A.; Kaptein T.M.; van Capel T.M.; Theelen B.; Boekhout T.; de Jong E.C.; Geijtenbeek T.B.; Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog 2011,7(1)","journal-title":"PLoS Pathog"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/eji.201242872","volume":"42","author":"Kuchroo V.K.","year":"2012","unstructured":"Kuchroo V.K.; Awasthi A.; Emerging new roles of Th17 cells. Eur J Immunol 2012,42(9),2211-2214","journal-title":"Eur J Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"Korn T.","year":"2009","unstructured":"Korn T.; Bettelli E.; Oukka M.; Kuchroo V.K.; IL-17 and Th17 Cells. Annu Rev Immunol 2009,27,485-517","journal-title":"Annu Rev Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","volume":"11","author":"Hern\u00e1ndez-Santos N.","year":"2012","unstructured":"Hern\u00e1ndez-Santos N.; Gaffen S.L.; Th17 cells in immunity to Candida albicans. Cell Host Microbe 2012,11(5),425-435","journal-title":"Cell Host Microbe"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003486","volume":"9","author":"De Luca A.","year":"2013","unstructured":"De Luca A.; Carvalho A.; Cunha C.; Iannitti R.G.; Pitzurra L.; Giovannini G.; Mencacci A.; Bartolommei L.; Moretti S.; Massi-Benedetti C.; Fuchs D.; De Bernardis F.; Puccetti P.; Romani L.; IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLoS Pathog 2013,9(7)","journal-title":"PLoS Pathog"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.chom.2012.04.004","volume":"11","author":"Casadevall A.","year":"2012","unstructured":"Casadevall A.; Pirofski L.A.; Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe 2012,11(5),447-456","journal-title":"Cell Host Microbe"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.riam.2011.07.004","volume":"29","author":"Calcedo R.","year":"2012","unstructured":"Calcedo R.; Ramirez-Garcia A.; Abad A.; Rementeria A.; Pont\u00f3n J.; Hernando F.L.; Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA. Rev Iberoam Micol 2012,29(3),172-174","journal-title":"Rev Iberoam Micol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","volume":"62","author":"Sandini S.","year":"2011","unstructured":"Sandini S.; La Valle R.; Deaglio S.; Malavasi F.; Cassone A.; De Bernardis F.; A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol 2011,62(2),215-224","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1128\/AAC.00892-10","volume":"55","author":"Brena S.","year":"2011","unstructured":"Brena S.; Cabezas-Olcoz J.; Moragues M.D.; Fern\u00e1ndez de Larrinoa I.; Dom\u00ednguez A.; Quind\u00f3s G.; Pont\u00f3n J.; Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans. Antimicrob Agents Chemother 2011,55(7),3156-3163","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350-6362.2005","volume":"73","author":"Martinez L.R.","year":"2005","unstructured":"Martinez L.R.; Casadevall A.; Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 2005,73(10),6350-6362","journal-title":"Infect Immun"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","volume":"71","author":"Moragues M.D.","year":"2003","unstructured":"Moragues M.D.; Omaetxebarria M.J.; Elguezabal N.; Sevilla M.J.; Conti S.; Polonelli L.; Pont\u00f3n J.; A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect Immun 2003,71(9),5273-5279","journal-title":"Infect Immun"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0010042","volume":"1","author":"Steele C.","year":"2005","unstructured":"Steele C.; Rapaka R.R.; Metz A.; Pop S.M.; Williams D.L.; Gordon S.; Kolls J.K.; Brown G.D.; The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005,1(4)","journal-title":"PLoS Pathog"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ni.2222","volume":"13","author":"Gringhuis S.I.","year":"2012","unstructured":"Gringhuis S.I.; Kaptein T.M.; Wevers B.A.; Theelen B.; van der Vlist M.; Boekhout T.; Geijtenbeek T.B.; Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1\u03b2 via a noncanonical caspase-8 inflammasome. Nat Immunol 2012,13(3),246-254","journal-title":"Nat Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature07965","volume":"459","author":"Gross O.","year":"2009","unstructured":"Gross O.; Poeck H.; Bscheider M.; Dostert C.; Hannesschl\u00e4ger N.; Endres S.; Hartmann G.; Tardivel A.; Schweighoffer E.; Tybulewicz V.; Mocsai A.; Tschopp J.; Ruland J.; Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009,459(7245),433-436","journal-title":"Nature"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1128\/EC.00336-13","volume":"13","author":"Wellington M.","year":"2014","unstructured":"Wellington M.; Koselny K.; Sutterwala F.S.; Krysan D.J.; Candida albicans triggers NLRP3-mediated pyroptosis in macrophages. Eukaryot Cell 2014,13(2),329-340","journal-title":"Eukaryot Cell"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002379","volume":"7","author":"Tomalka J.","year":"2011","unstructured":"Tomalka J.; Ganesan S.; Azodi E.; Patel K.; Majmudar P.; Hall B.A.; Fitzgerald K.A.; Hise A.G.; A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 2011,7(12)","journal-title":"PLoS Pathog"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","volume":"113","author":"Netea M.G.","year":"2009","unstructured":"Netea M.G.; Nold-Petry C.A.; Nold M.F.; Joosten L.A.; Opitz B.; van der Meer J.H.; van de Veerdonk F.L.; Ferwerda G.; Heinhuis B.; Devesa I.; Funk C.J.; Mason R.J.; Kullberg B.J.; Rubartelli A.; van der Meer J.W.; Dinarello C.A.; Differential requirement for the activation of the inflammasome for processing and release of IL-1\u03b2 in monocytes and macrophages. Blood 2009,113(10),2324-2335","journal-title":"Blood"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1086\/597274","volume":"199","author":"van de Veerdonk F.L.","year":"2009","unstructured":"van de Veerdonk F.L.; Joosten L.A.; Devesa I.; Mora-Montes H.M.; Kanneganti T-D.; Dinarello C.A.; van der Meer J.W.; Gow N.A.; Kullberg B.J.; Netea M.G.; Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1\u03b2 production by the fungal pathogen Candida albicans. J Infect Dis 2009,199(7),1087-1096","journal-title":"J Infect Dis"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"Brown G.D.","year":"2012","unstructured":"Brown G.D.; Denning D.W.; Gow N.A.; Levitz S.M.; Netea M.G.; White T.C.; Hidden killers: human fungal infections. Science translational medicine 2012,4(165)","journal-title":"Science translational medicine"},{"key":"ref=70","first-page":"67","author":"Calderone R.","year":"2002","unstructured":"Calderone R.; Gow N.A.; Host recognition by Candida species Candida and candidiasis 2002,67-86","journal-title":"Host recognition by Candida species Candida and candidiasis"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clindermatol.2009.12.014","volume":"28","author":"L\u00f3pez-Mart\u00ednez R.","year":"2010","unstructured":"L\u00f3pez-Mart\u00ednez R.; Candidosis, a new challenge. Clin Dermatol 2010,28(2),178-184","journal-title":"Clin Dermatol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1128\/JCM.37.12.3896-3900.1999","volume":"37","author":"Redding S.W.","year":"1999","unstructured":"Redding S.W.; Zellars R.C.; Kirkpatrick W.R.; McAtee R.K.; Caceres M.A.; Fothergill A.W.; Lopez-Ribot J.L.; Bailey C.W.; Rinaldi M.G.; Patterson T.F.; Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 1999,37(12),3896-3900","journal-title":"J Clin Microbiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","volume":"109","author":"Thompson G.R.","year":"2010","unstructured":"Thompson G.R.; Patel P.K.; Kirkpatrick W.R.; Westbrook S.D.; Berg D.; Erlandsen J.; Redding S.W.; Patterson T.F.; Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010,109(4),488-495","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/apc.1998.12.359","volume":"12","author":"Fidel P.L.","year":"1998","unstructured":"Fidel P.L.; Vaginal candidiasis: review and role of local mucosal immunity. AIDS Patient Care STDS 1998,12(5),359-366","journal-title":"AIDS Patient Care STDS"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/520192","volume":"29","author":"Edmond M.B.","year":"1999","unstructured":"Edmond M.B.; Wallace S.E.; McClish D.K.; Pfaller M.A.; Jones R.N.; Wenzel R.P.; Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999,29(2),239-244","journal-title":"Clin Infect Dis"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrd3074","volume":"9","author":"Ostrosky-Zeichner L.","year":"2010","unstructured":"Ostrosky-Zeichner L.; Casadevall A.; Galgiani J.N.; Odds F.C.; Rex J.H.; An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 2010,9(9),719-727","journal-title":"Nat Rev Drug Discov"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","volume":"11","author":"Odds F.C.","year":"2003","unstructured":"Odds F.C.; Brown A.J.; Gow N.A.; Antifungal agents: mechanisms of action. Trends Microbiol 2003,11(6),272-279","journal-title":"Trends Microbiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","volume":"45","author":"Perea S.","year":"2001","unstructured":"Perea S.; L\u00f3pez-Ribot J.L.; Kirkpatrick W.R.; McAtee R.K.; Santill\u00e1n R.A.; Mart\u00ednez M.; Calabrese D.; Sanglard D.; Patterson T.F.; Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2001,45(10),2676-2684","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1128\/AAC.48.4.1382-1383.2004","volume":"48","author":"Hernandez S.","year":"2004","unstructured":"Hernandez S.; L\u00f3pez-Ribot J.L.; Najvar L.K.; McCarthy D.I.; Bocanegra R.; Graybill J.R.; Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis. Antimicrob Agents Chemother 2004,48(4),1382-1383","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1128\/AAC.00959-08","volume":"52","author":"Wiederhold N.P.","year":"2008","unstructured":"Wiederhold N.P.; Grabinski J.L.; Garcia-Effron G.; Perlin D.S.; Lee S.A.; Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrob Agents Chemother 2008,52(11),4145-4148","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019752","volume":"5","author":"Cowen L.E.","year":"2014","unstructured":"Cowen L.E.; Sanglard D.; Howard S.J.; Rogers P.D.; Perlin D.S.; Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med 2014,5(7)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1128\/CMR.11.2.382","volume":"11","author":"White T.C.","year":"1998","unstructured":"White T.C.; Marr K.A.; Bowden R.A.; Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998,11(2),382-402","journal-title":"Clin Microbiol Rev"},{"key":"ref=83","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00662","volume":"4","author":"Ford C.B.","year":"2015","unstructured":"Ford C.B.; Funt J.M.; Abbey D.; Issi L.; Guiducci C.; Martinez D.A.; Delorey T.; Li B.Y.; White T.C.; Cuomo C.; Rao R.P.; Berman J.; Thompson D.A.; Regev A.; The evolution of drug resistance in clinical isolates of Candida albicans. eLife 2015,4","journal-title":"eLife"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","volume":"45","author":"Revie N.M.","year":"2018","unstructured":"Revie N.M.; Iyer K.R.; Robbins N.; Cowen L.E.; Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol 2018,45,70-76","journal-title":"Curr Opin Microbiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"E461","DOI":"10.3390\/genes9090461","volume":"9","author":"Ksiezopolska E.","year":"2018","unstructured":"Ksiezopolska E.; Gabald\u00f3n T.; Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes (Basel) 2018,9(9),E461","journal-title":"Genes (Basel)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"Whaley S.G.","year":"2017","unstructured":"Whaley S.G.; Berkow E.L.; Rybak J.M.; Nishimoto A.T.; Barker K.S.; Rogers P.D.; Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 2017,7,2173","journal-title":"Front Microbiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/jphp.12780","volume":"69","author":"Patil A.","year":"2017","unstructured":"Patil A.; Majumdar S.; Echinocandins in antifungal pharmacotherapy. J Pharm Pharmacol 2017,69(12),1635-1660","journal-title":"J Pharm Pharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"Perlin D.S.","year":"2015","unstructured":"Perlin D.S.; Echinocandin resistance in candida. Clin Infect Dis 2015,61(Suppl. 6),S612-S617","journal-title":"Clin Infect Dis"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1128\/EC.00103-08","volume":"7","author":"Dunkel N.","year":"2008","unstructured":"Dunkel N.; Liu T.T.; Barker K.S.; Homayouni R.; Morschh\u00e4user J.; Rogers P.D.; A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot Cell 2008,7(7),1180-1190","journal-title":"Eukaryot Cell"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/AAC.44.1.63-67.2000","volume":"44","author":"Lamb D.C.","year":"2000","unstructured":"Lamb D.C.; Kelly D.E.; White T.C.; Kelly S.L.; The R467K amino acid substitution in Candida albicans sterol 14 \u03b1-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother 2000,44(1),63-67","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"Morio F.","year":"2010","unstructured":"Morio F.; Loge C.; Besse B.; Hennequin C.; Le Pape P.; Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 2010,66(4),373-384","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"Perlin D.S.","year":"2015","unstructured":"Perlin D.S.; Echinocandin resistance in Candida. Clin Infect Dis 2015,61(suppl_6),S612-S617","journal-title":"Clin Infect Dis"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"7715","DOI":"10.1128\/AAC.02204-15","volume":"59","author":"Asner S.A.","year":"2015","unstructured":"Asner S.A.; Giulieri S.; Diezi M.; Marchetti O.; Sanglard D.; Acquired multidrug antifungal resistance in Candida lusitaniae during therapy. Antimicrob Agents Chemother 2015,59(12),7715-7722","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1128\/JCM.00325-11","volume":"49","author":"Desnos-Ollivier M.","year":"2011","unstructured":"Desnos-Ollivier M.; Moquet O.; Chouaki T.; Gu\u00e9rin A-M.; Dromer F.; Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment. J Clin Microbiol 2011,49(6),2304-2306","journal-title":"J Clin Microbiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1128\/AAC.00088-08","volume":"52","author":"Desnos-Ollivier M.","year":"2008","unstructured":"Desnos-Ollivier M.; Bretagne S.; Raoux D.; Hoinard D.; Dromer F.; Dannaoui E.; Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the european committee on antibiotic susceptibility testing. Antimicrob Agents Chemother 2008,52(9),3092-3098","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1128\/AAC.00262-08","volume":"52","author":"Garcia-Effron G.","year":"2008","unstructured":"Garcia-Effron G.; Katiyar S.K.; Park S.; Edlind T.D.; Perlin D.S.; A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 2008,52(7),2305-2312","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1128\/AAC.49.9.3646-3651.2005","volume":"49","author":"Chau A.S.","year":"2005","unstructured":"Chau A.S.; Gurnani M.; Hawkinson R.; Laverdiere M.; Cacciapuoti A.; McNicholas P.M.; Inactivation of sterol \u03945,6-desaturase attenuates virulence in Candida albicans. Antimicrob Agents Chemother 2005,49(9),3646-3651","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/AAC.00555-13","volume":"57","author":"Eddouzi J.","year":"2013","unstructured":"Eddouzi J.; Parker J.E.; Vale-Silva L.A.; Coste A.; Ischer F.; Kelly S.; Manai M.; Sanglard D.; Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob Agents Chemother 2013,57(7),3182-3193","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/AAC.00348-10","volume":"54","author":"Martel C.M.","year":"2010","unstructured":"Martel C.M.; Parker J.E.; Bader O.; Weig M.; Gross U.; Warrilow A.G.; Rolley N.; Kelly D.E.; Kelly S.L.; Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob Agents Chemother 2010,54(11),4527-4533","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/jac\/dks186","volume":"67","author":"Morio F.","year":"2012","unstructured":"Morio F.; Pagniez F.; Lacroix C.; Miegeville M.; Le Pape P.; Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J Antimicrob Chemother 2012,67(9),2131-2138","journal-title":"J Antimicrob Chemother"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1006\/bbrc.1995.1272","volume":"207","author":"Kelly S.L.","year":"1995","unstructured":"Kelly S.L.; Lamb D.C.; Corran A.J.; Baldwin B.C.; Kelly D.E.; Mode of action and resistance to azole antifungals associated with the formation of 14 \u03b1-methylergosta-8,24(28)-dien-3 \u03b2,6 \u03b1-diol. Biochem Biophys Res Commun 1995,207(3),910-915","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1128\/AAC.42.5.1160","volume":"42","author":"Jensen-Pergakes K.L.","year":"1998","unstructured":"Jensen-Pergakes K.L.; Kennedy M.A.; Lees N.D.; Barbuch R.; Koegel C.; Bard M.; Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants. Antimicrob Agents Chemother 1998,42(5),1160-1167","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.46.4.947-957.2002","volume":"46","author":"Jia N.","year":"2002","unstructured":"Jia N.; Arthington-Skaggs B.; Lee W.; Pierson C.A.; Lees N.D.; Eckstein J.; Barbuch R.; Bard M.; Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 2002,46(4),947-957","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"Vincent B.M.","year":"2013","unstructured":"Vincent B.M.; Lancaster A.K.; Scherz-Shouval R.; Whitesell L.; Lindquist S.; Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol 2013,11(10)","journal-title":"PLoS Biol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/1471-2164-9-579","volume":"9","author":"Gaur M.","year":"2008","unstructured":"Gaur M.; Puri N.; Manoharlal R.; Rai V.; Mukhopadhayay G.; Choudhury D.; Prasad R.; MFS transportome of the human pathogenic yeast Candida albicans. BMC Genomics 2008,9(1),579","journal-title":"BMC Genomics"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1567-1364.2006.00058.x","volume":"6","author":"Gbelska Y.","year":"2006","unstructured":"Gbelska Y.; Krijger J-J.; Breunig K.D.; Evolution of gene families: the multidrug resistance transporter genes in five related yeast species. FEMS Yeast Res 2006,6(3),345-355","journal-title":"FEMS Yeast Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmed.2016.00011","volume":"3","author":"Sanglard D.","year":"2016","unstructured":"Sanglard D.; Emerging threats in antifungal-resistant fungal pathogens. Front Med (Lausanne) 2016,3,11","journal-title":"Front Med (Lausanne)"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"Sanglard D.","year":"2009","unstructured":"Sanglard D.; Coste A.; Ferrari S.; Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 2009,9(7),1029-1050","journal-title":"FEMS Yeast Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","volume":"4","author":"Ramage G.","year":"2005","unstructured":"Ramage G.; Saville S.P.; Thomas D.P.; L\u00f3pez-Ribot J.L.; Candida biofilms: an update. Eukaryot Cell 2005,4(4),633-638","journal-title":"Eukaryot Cell"},{"key":"ref=110","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019729","volume":"4","author":"Desai J.V.","year":"2014","unstructured":"Desai J.V.; Mitchell A.P.; Andes D.R.; Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb Perspect Med 2014,4(10)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1073\/pnas.1421437112","volume":"112","author":"Mitchell K.F.","year":"2015","unstructured":"Mitchell K.F.; Zarnowski R.; Sanchez H.; Edward J.A.; Reinicke E.L.; Nett J.E.; Mitchell A.P.; Andes D.R.; Community participation in biofilm matrix assembly and function. Proc Natl Acad Sci USA 2015,112(13),4092-4097","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1128\/AAC.01638-09","volume":"54","author":"Vediyappan G.","year":"2010","unstructured":"Vediyappan G.; Rossignol T.; d\u2019Enfert C.; Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Antimicrob Agents Chemother 2010,54(5),2096-2111","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nchembio.2007.24","volume":"3","author":"Clatworthy A.E.","year":"2007","unstructured":"Clatworthy A.E.; Pierson E.; Hung D.T.; Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 2007,3(9),541-548","journal-title":"Nat Chem Biol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","volume":"14","author":"Gauwerky K.","year":"2009","unstructured":"Gauwerky K.; Borelli C.; Korting H.C.; Targeting virulence: a new paradigm for antifungals. Drug Discov Today 2009,14(3-4),214-222","journal-title":"Drug Discov Today"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro732","volume":"1","author":"Casadevall A.","year":"2003","unstructured":"Casadevall A.; Pirofski L.A.; The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 2003,1(1),17-24","journal-title":"Nat Rev Microbiol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1574-6976.2010.00232.x","volume":"34","author":"van de Veerdonk F.L.","year":"2010","unstructured":"van de Veerdonk F.L.; Netea M.G.; Joosten L.A.; van der Meer J.W.; Kullberg B.J.; Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy. FEMS Microbiol Rev 2010,34(6),1063-1075","journal-title":"FEMS Microbiol Rev"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","volume":"190","author":"Huang W.","year":"2004","unstructured":"Huang W.; Na L.; Fidel P.L.; Schwarzenberger P.; Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004,190(3),624-631","journal-title":"J Infect Dis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20081463","volume":"206","author":"Conti H.R.","year":"2009","unstructured":"Conti H.R.; Shen F.; Nayyar N.; Stocum E.; Sun J.N.; Lindemann M.J.; Ho A.W.; Hai J.H.; Yu J.J.; Jung J.W.; Filler S.G.; Masso-Welch P.; Edgerton M.; Gaffen S.L.; Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009,206(2),299-311","journal-title":"J Exp Med"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"Torosantucci A.","year":"2005","unstructured":"Torosantucci A.; Bromuro C.; Chiani P.; De Bernardis F.; Berti F.; Galli C.; Norelli F.; Bellucci C.; Polonelli L.; Costantino P.; Rappuoli R.; Cassone A.; A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005,202(5),597-606","journal-title":"J Exp Med"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1086\/314779","volume":"179","author":"Han Y.","year":"1999","unstructured":"Han Y.; Ulrich M.A.; Cutler J.E.; Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J Infect Dis 1999,179(6),1477-1484","journal-title":"J Infect Dis"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/IAI.51.2.668-674.1986","volume":"51","author":"Bistoni F.","year":"1986","unstructured":"Bistoni F.; Vecchiarelli A.; Cenci E.; Puccetti P.; Marconi P.; Cassone A.; Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986,51(2),668-674","journal-title":"Infect Immun"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","volume":"28","author":"Pietrella D.","year":"2010","unstructured":"Pietrella D.; Rachini A.; Torosantucci A.; Chiani P.; Brown A.J.; Bistoni F.; Costantino P.; Mosci P.; d\u2019Enfert C.; Rappuoli R.; Cassone A.; Vecchiarelli A.; A \u03b2-glucan-conjugate vaccine and anti-\u03b2-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 2010,28(7),1717-1725","journal-title":"Vaccine"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/BF01690878","volume":"14","author":"Graybill J.R.","year":"1995","unstructured":"Graybill J.R.; Bocanegra R.; Luther M.; Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. Eur J Clin Microbiol Infect Dis 1995,14(8),700-703","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/infdis\/168.2.436","volume":"168","author":"Kullberg B-J.","year":"1993","unstructured":"Kullberg B-J.; van \u2019t Wout J.W.; Hoogstraten C.; van Furth R.; Recombinant interferon-\u03b3 enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993,168(2),436-443","journal-title":"J Infect Dis"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cbi.2018.12.009","volume":"299","author":"Dua K.","year":"2019","unstructured":"Dua K.; Malyla V.; Singhvi G.; Wadhwa R.; Krishna R.V.; Shukla S.D.; Shastri M.D.; Chellappan D.K.; Maurya P.K.; Satija S.; Mehta M.; Gulati M.; Hansbro N.; Collet T.; Awasthi R.; Gupta G.; Hsu A.; Hansbro P.M.; Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems. Chem Biol Interact 2019,299,168-178","journal-title":"Chem Biol Interact"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s13346-016-0343-6","volume":"7","author":"Dua K.","year":"2017","unstructured":"Dua K.; Hansbro N.G.; Foster P.S.; Hansbro P.M.; MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases. Drug Deliv Transl Res 2017,7(1),168-178","journal-title":"Drug Deliv Transl Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.biopha.2018.08.101","volume":"107","author":"Dua K.","year":"2018","unstructured":"Dua K.; Rapalli V.K.; Shukla S.D.; Singhvi G.; Shastri M.D.; Chellappan D.K.; Satija S.; Mehta M.; Gulati M.; Pinto T.J.A.; Gupta G.; Hansbro P.M.; Multi-drug resistant Mycobacterium tuberculosis","journal-title":"Biomed Pharmacother"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/10837450.2014.999783","volume":"21","author":"Pinto Reis C.","year":"2016","unstructured":"Pinto Reis C.; Vasques Roque L.; Baptista M.; Rijo P.; Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. Pharm Dev Technol 2016,21(3),282-287","journal-title":"Pharm Dev Technol"},{"key":"ref=129","first-page":"584","volume":"6","author":"Balamurugan J.","year":"2014","unstructured":"Balamurugan J.; Vijayalakshmi P.; Preparation and evaluation of floating extended release matrix tablet using combination of polymethacrylates and polyethylene oxide polymers. Int J Pharm Pharm Sci 2014,6(8),584-592","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3109\/10717544.2014.943337","volume":"23","author":"Salunkhe S.S.","year":"2016","unstructured":"Salunkhe S.S.; Bhatia N.M.; Bhatia M.S.; Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain. Drug Deliv 2016,23(4),1306-1316","journal-title":"Drug Deliv"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1002\/jps.23249","volume":"101","author":"Fern\u00e1ndez Campos F.","year":"2012","unstructured":"Fern\u00e1ndez Campos F.; Calpena Campmany A.C.; Rodr\u00edguez Delgado G.; L\u00f3pez Serrano O.; Clares Naveros B.; Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. J Pharm Sci 2012,101(10),3739-3752","journal-title":"J Pharm Sci"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","volume":"37","author":"El-Ridy M.S.","year":"2011","unstructured":"El-Ridy M.S.; Abdelbary A.; Essam T.; El-Salam R.M.; Kassem A.A.; Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm 2011,37(12),1491-1508","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/1061186031000119093","volume":"11","author":"Khan M.A.","year":"2003","unstructured":"Khan M.A.; Syed F.M.; Nasti H.T.; Saima Dagger K.; Haq W.; Shehbaz A.; Owais M.; Use of tuftsin bearing nystatin liposomes against an isolate of Candida albicans showing less in vivo susceptibility to amphotericin B. J Drug Target 2003,11(2),93-99","journal-title":"J Drug Target"},{"key":"ref=134","doi-asserted-by":"publisher","DOI":"10.1208\/pt050335","volume":"5","author":"Desai K.G.H.","year":"2004","unstructured":"Desai K.G.H.; Kumar T.M.; Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech 2004,5(3)","journal-title":"AAPS PharmSciTech"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jsps.2014.11.004","volume":"23","author":"Al-Quadeib B.T.","year":"2015","unstructured":"Al-Quadeib B.T.; Radwan M.A.; Siller L.; Horrocks B.; Wright M.C.; Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharm J 2015,23(3),290-302","journal-title":"Saudi Pharm J"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3109\/10717544.2016.1153747","volume":"23","author":"Hussain A.","year":"2016","unstructured":"Hussain A.; Singh V.K.; Singh O.P.; Shafaat K.; Kumar S.; Ahmad F.J.; Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B. Drug Deliv 2016,23(8),3101-3110","journal-title":"Drug Deliv"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1166\/jbn.2011.1332","volume":"7","author":"Patel P.A.","year":"2011","unstructured":"Patel P.A.; Patravale V.B.; AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J Biomed Nanotechnol 2011,7(5),632-639","journal-title":"J Biomed Nanotechnol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","volume":"69","author":"Moen M.D.","year":"2009","unstructured":"Moen M.D.; Lyseng-Williamson K.A.; Scott L.J.; Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 2009,69(3),361-392","journal-title":"Drugs"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0250-474X.151601","volume":"77","author":"Patel S.K.","year":"2015","unstructured":"Patel S.K.; Shah D.R.; Tiwari S.; Bioadhesive films containing fluconazole for mucocutaneous candidiasis. Indian J Pharm Sci 2015,77(1),55-61","journal-title":"Indian J Pharm Sci"},{"key":"ref=140","first-page":"2009","volume":"4","author":"Kumar J.R.K.","year":"2012","unstructured":"Kumar J.R.K.; Muralidharan S.; Dhanaraj S.A.; Development and in vitro evalution of guar gum based fluconazole in situ gel for oral thrush. J Pharm Sci Rev Res 2012,4(12),2009","journal-title":"J Pharm Sci Rev Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/21691401.2014.909822","volume":"44","author":"Jaiswal P.","year":"2016","unstructured":"Jaiswal P.; Gidwani B.; Vyas A.; Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol 2016,44(1),27-40","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=142","first-page":"368","volume":"47","author":"Bhalaria M.","year":"2009","unstructured":"Bhalaria M.; Naik S.; Misra A.; Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. Indian J Exp Biol 2009,47(5),368-375","journal-title":"Indian J Exp Biol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1208\/s12249-009-9257-7","volume":"10","author":"Maiti S.","year":"2009","unstructured":"Maiti S.; Dey P.; Kaity S.; Ray S.; Maji S.; Sa B.; Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS PharmSciTech 2009,10(3),703-715","journal-title":"AAPS PharmSciTech"},{"key":"ref=144","first-page":"30","volume":"24","author":"Shahzadi I.","year":"2014","unstructured":"Shahzadi I.; Masood M.I.; Chowdhary F.; Anjum A.A.; Nawaz M.A.; Maqsood I.; Zaman M.Q.; Microemulsion formulation for topical delivery of miconazole nitrate. Int J Pharm Sci Rev Res 2014,24(2),30-36","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/10837450.2019.1578372","volume":"24","author":"Lambert E.","year":"2019","unstructured":"Lambert E.; Janjic J.M.; Multiple linear regression applied to predicting droplet size of complex perfluorocarbon nanoemulsions for biomedical applications. Pharm Dev Technol 2019,24(6),700-710","journal-title":"Pharm Dev Technol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"162","DOI":"10.22270\/jddt.v8i3.1772","volume":"8","author":"Chauhan P.","year":"2018","unstructured":"Chauhan P.; Tyagi B.K.; Herbal novel drug delivery systems and transfersomes. J Drug Deliv Ther 2018,8(3),162-168","journal-title":"J Drug Deliv Ther"},{"key":"ref=147","unstructured":"An efficacy and safety study of APX001 in non-neutropenic patients with candidemia. Available from: (Accessed on February 15, 2019)."},{"key":"ref=148","unstructured":"A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal candidiasis (Yeast Infection). Available from: (Accessed February 15, 2019)."},{"key":"ref=149","unstructured":"Oral SCY-078 vs. standard-of-care following IV echinocandin in the treatment of invasive candidiasis. Available from: (Accessed on February 16, 2019)."},{"key":"ref=150","unstructured":"Open-label study to evaluate the efficacy and safety of scy-078 in patients with candidiasis caused by Candida auris (CARES). Available from: [Accessed on February 16, 2019]."},{"key":"ref=151","unstructured":"CD101 compared to caspofungin followed by oral step down in subjects with candidemia and\/or invasive candidiasis-bridging extension (STRIVE). Available from: (Accessed on February 16, 2019)."},{"key":"ref=152","unstructured":"A study to evaluate oral vt-1161 in the treatment of patients with recurrent vaginal candidiasis (yeast infection). Available from: (Accessed on February 16, 2019)."},{"key":"ref=153","unstructured":"Safety and efficacy of oral encochleated amphotericin b (CAMB\/MAT2203) in the treatment of vulvovaginal candidiasis (VVC). Available from: (Accessed on February 16, 2019)"},{"key":"ref=154","unstructured":"CAMB\/MAT2203 in patients with mucocutaneous candidiasis (CAMB). Available from: (Accessed on February 16, 2019)"},{"key":"ref=155","unstructured":"Efficacy and safety of oral encochleated amphotericin b (CAMB) in the treatment of fluconazole-resistant vulvovaginal candidiasis. Available from: (Accessed on February 16, 2019)"},{"key":"ref=156","unstructured":"CelAgace\u2122 orarinse solution for treatment of candidiasis. Available from: (Accessed on February 16, 2019)."},{"key":"ref=157","unstructured":"A comparative clinical trial to evaluate the safety and clinical equivalence of clotrimazole troche\/lozenges USP, 10mg (unique pharmaceutical laboratories, India) with clotrimazole troche 10mg (roxane laboratories inc., usa) in subjects with oropharyngeal candidiasis. (TPC). Available from: (Accessed on February 16, 2019)."},{"key":"ref=158","unstructured":"Patients with vulvovaginal candidiasis (EPP-AFG-VVC). Available from: (Accessed February 16, 2019)."},{"key":"ref=159","unstructured":"The safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis (FRMC). Available from: (Accessed on February 16, 2019)."},{"key":"ref=160","unstructured":"Study to compare the efficacy and safety of micafungin versus conventional amphotericin b for the treatment of neonatal candidiasis (MAGIC-2). Available from: (Accessed February 16, 2019)."},{"key":"ref=161","unstructured":"Gentian violet vs. Available from: (Accessed on February 16, 2019)."}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T17:58:35Z","timestamp":1612375115000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176193\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":161,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2019,12,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026619666191026105308","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}